Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 09:08 am Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Deep Track Capital LP | 1,900,000 4% | 1,334 (+0.07%) | View |
2022-02-14 09:01 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 2,450,000 4% | -640,200 (-20.72%) | View |
2022-02-14 09:00 am Sale | 13G | AVROBIO INC AVRO | Deep Track Capital LP | 1,050,132 2.41% | -1,160,997 (-52.51%) | View |
2022-02-14 09:00 am Sale | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,100,000 5.03% | -4,600 (-0.22%) | View |
2022-02-14 08:59 am Purchase | 13G | PASSAGE BIO INC PASG | Deep Track Capital LP | 3,216,997 5.95% | 364,057 (+12.76%) | View |
2022-02-14 08:58 am Purchase | 13G | MAGENTA THERAPEUTICS INC MGTA | Deep Track Capital LP | 4,870,000 8.29% | 714,445 (+17.19%) | View |
2022-02-14 08:58 am Purchase | 13G | KEROS THERAPEUTICS INC KROS | Deep Track Capital LP | 1,300,000 5.5% | 11,276 (+0.87%) | View |
2022-02-14 08:57 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Deep Track Capital LP | 1,500,000 6.13% | 233,116 (+18.40%) | View |
2022-02-14 08:56 am Purchase | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 4,000,000 7.81% | 143,537 (+3.72%) | View |
2022-02-14 08:56 am Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 1,900,000 5.91% | 100,000 (+5.56%) | View |
2022-02-14 08:55 am Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Deep Track Capital LP | 3,000,000 6.27% | 606,124 (+25.32%) | View |
2022-02-11 5:11 pm Purchase | 13G | IMMUNOVANT INC IMVT | Deep Track Capital LP | 6,780,827 5.83% | 6,780,827 (New Position) | View |
2022-02-03 9:43 pm Purchase | 13G | KURA ONCOLOGY INC KURA | Deep Track Capital LP | 3,362,000 5.05% | 3,362,000 (New Position) | View |
2022-01-27 4:35 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital LP | 1,496,138 5.09% | 1,496,138 (New Position) | View |
2022-01-27 4:34 pm Purchase | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital LP | 2,414,917 5.97% | 2,414,917 (New Position) | View |
2022-01-20 4:27 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 2,816,950 5.47% | 2,816,950 (New Position) | View |
2021-12-30 4:37 pm Purchase | 13G | KEROS THERAPEUTICS INC KROS | Deep Track Capital LP | 1,288,724 5.45% | 1,288,724 (New Position) | View |
2021-12-09 4:54 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Deep Track Capital LP | 6,345,790 9.99% | 6,345,790 (New Position) | View |
2021-11-17 4:11 pm Purchase | 13G | TRICIDA INC TCDA | Deep Track Capital LP | 5,857,829 9.99% | 5,857,829 (New Position) | View |
2021-11-04 5:02 pm Purchase | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 1,800,000 5.69% | 1,800,000 (New Position) | View |